HEADER TRANSFERASE 19-AUG-08 3E8D TITLE CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- TITLE 2 COMPETITIVE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-BETA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: AKT2 KINASE DOMAIN (UNP RESIDUES 146-480); COMPND 5 SYNONYM: RAC-PK-BETA, PROTEIN KINASE AKT-2, PROTEIN KINASE B, BETA, COMPND 6 PKB BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA PEPTIDE; COMPND 12 CHAIN: C, D; COMPND 13 SYNONYM: GSK-3 BETA; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT IS FOUND SOURCE 12 NATURALLY IN HUMAN. KEYWDS AKT2, KINASE, GSK3 BETA, ATP-BINDING, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT KEYWDS 3 SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR N.O.CONCHA,P.A.ELKINS,A.SMALLWOOD,P.WARD REVDAT 7 20-OCT-21 3E8D 1 REMARK SEQADV LINK REVDAT 6 25-OCT-17 3E8D 1 REMARK REVDAT 5 19-NOV-14 3E8D 1 FORMUL HETNAM REVDAT 4 13-JUL-11 3E8D 1 VERSN REVDAT 3 17-MAR-09 3E8D 1 JRNL REVDAT 2 24-FEB-09 3E8D 1 VERSN REVDAT 1 14-OCT-08 3E8D 0 JRNL AUTH M.B.ROUSE,M.A.SEEFELD,J.D.LEBER,K.C.MCNULTY,L.SUN, JRNL AUTH 2 W.H.MILLER,S.ZHANG,E.A.MINTHORN,N.O.CONCHA,A.E.CHOUDHRY, JRNL AUTH 3 M.D.SCHABER,D.A.HEERDING JRNL TITL AMINOFURAZANS AS POTENT INHIBITORS OF AKT KINASE JRNL REF BIOORG.MED.CHEM.LETT. V. 19 1508 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19179070 JRNL DOI 10.1016/J.BMCL.2009.01.002 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.SEEFELD,M.B.ROUSE,K.C.MCNULTY,L.SUN,J.WANG, REMARK 1 AUTH 2 D.S.YAMASHITA,A.CHOUDHRY,M.D.SCHABER,R.KUMAR,J.KAHANA, REMARK 1 AUTH 3 S.Y.ZHANG,E.A.MINTHORN,K.K.KORETKE,N.O.CONCHA,D.A.HEERDING REMARK 1 TITL DISCOVERY OF 5-PYRROLOPYRIDINYL-2-THIOPHENECARBOXAMIDES AS REMARK 1 TITL 2 POTENT AKT KINASE INHIBITORS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 971 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1310 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3530 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3540 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5341 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 41 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.19000 REMARK 3 B22 (A**2) : 0.19000 REMARK 3 B33 (A**2) : -0.28000 REMARK 3 B12 (A**2) : 0.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.407 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.295 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.746 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.864 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5547 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3888 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7485 ; 1.160 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9381 ; 0.768 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 652 ; 5.185 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 272 ;33.179 ;23.088 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 980 ;13.503 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 47 ;14.084 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 792 ; 0.054 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6079 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1216 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1123 ; 0.183 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3955 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2715 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2850 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 133 ; 0.125 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 20 ; 0.115 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 83 ; 0.214 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.109 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3354 ; 0.212 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1322 ; 0.030 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5248 ; 0.376 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2612 ; 0.378 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2235 ; 0.647 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 146 A 480 2 REMARK 3 1 B 146 B 480 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1865 ; 0.01 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 A (A): 2580 ; 0.21 ; 0.50 REMARK 3 TIGHT THERMAL 1 A (A**2): 1865 ; 0.01 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2580 ; 0.06 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 3 C 12 2 REMARK 3 1 D 3 D 12 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 C (A): 57 ; 0.01 ; 0.05 REMARK 3 MEDIUM POSITIONAL 2 C (A): 82 ; 0.36 ; 0.50 REMARK 3 TIGHT THERMAL 2 C (A**2): 57 ; 0.01 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 82 ; 0.30 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 146 A 480 REMARK 3 RESIDUE RANGE : C 3 C 12 REMARK 3 ORIGIN FOR THE GROUP (A): 34.0560 -29.6070 -3.9240 REMARK 3 T TENSOR REMARK 3 T11: -0.0461 T22: -0.0355 REMARK 3 T33: -0.0513 T12: -0.0209 REMARK 3 T13: -0.0044 T23: -0.0098 REMARK 3 L TENSOR REMARK 3 L11: 0.5285 L22: 1.6256 REMARK 3 L33: 1.0348 L12: 0.0287 REMARK 3 L13: 0.1765 L23: -0.1771 REMARK 3 S TENSOR REMARK 3 S11: -0.0468 S12: -0.0034 S13: 0.0302 REMARK 3 S21: 0.0167 S22: 0.0531 S23: 0.0214 REMARK 3 S31: -0.0824 S32: -0.0136 S33: -0.0063 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 146 B 480 REMARK 3 RESIDUE RANGE : D 3 D 12 REMARK 3 ORIGIN FOR THE GROUP (A): -8.6100 -44.2970 3.5870 REMARK 3 T TENSOR REMARK 3 T11: -0.0549 T22: -0.0277 REMARK 3 T33: -0.0518 T12: 0.0164 REMARK 3 T13: -0.0098 T23: 0.0013 REMARK 3 L TENSOR REMARK 3 L11: 1.3225 L22: 0.7593 REMARK 3 L33: 0.9992 L12: 0.4626 REMARK 3 L13: -0.0195 L23: -0.1935 REMARK 3 S TENSOR REMARK 3 S11: 0.0183 S12: 0.0632 S13: 0.0438 REMARK 3 S21: 0.0511 S22: -0.0178 S23: -0.0381 REMARK 3 S31: -0.0488 S32: 0.0633 S33: -0.0005 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3E8D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000049003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : UN-FOCUSED BEAM REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18873 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 41.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.23300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.82000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 2KMME, 100 MM TRIS PH 8.0 AND REMARK 280 10% ETHANOL DIFFUSED IN. SEEDED., VAPOR DIFFUSION, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.06800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 15.03400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 449 REMARK 465 ILE A 450 REMARK 465 TPO A 451 REMARK 465 PRO A 452 REMARK 465 PRO A 453 REMARK 465 ASP A 454 REMARK 465 ARG A 455 REMARK 465 TYR A 456 REMARK 465 ASP A 457 REMARK 465 SER A 458 REMARK 465 LEU A 459 REMARK 465 GLY A 460 REMARK 465 LEU A 461 REMARK 465 LEU A 462 REMARK 465 GLU A 463 REMARK 465 LEU A 464 REMARK 465 ASP A 465 REMARK 465 GLN A 466 REMARK 465 ARG A 467 REMARK 465 THR B 449 REMARK 465 ILE B 450 REMARK 465 TPO B 451 REMARK 465 PRO B 452 REMARK 465 PRO B 453 REMARK 465 ASP B 454 REMARK 465 ARG B 455 REMARK 465 TYR B 456 REMARK 465 ASP B 457 REMARK 465 SER B 458 REMARK 465 LEU B 459 REMARK 465 GLY B 460 REMARK 465 LEU B 461 REMARK 465 LEU B 462 REMARK 465 GLU B 463 REMARK 465 LEU B 464 REMARK 465 ASP B 465 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 163 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 163 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR D 8 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 245 -47.21 76.17 REMARK 500 ASP A 275 42.04 -147.53 REMARK 500 ASP A 293 96.17 63.93 REMARK 500 ASN A 325 -141.82 61.33 REMARK 500 LEU A 385 33.17 -96.09 REMARK 500 ASP A 399 -114.30 57.67 REMARK 500 GLN A 429 43.94 -89.67 REMARK 500 PHE A 473 -142.42 -107.17 REMARK 500 ARG B 245 -46.61 76.73 REMARK 500 ASP B 275 43.19 -147.17 REMARK 500 ASP B 293 95.04 64.68 REMARK 500 ASN B 325 -142.23 61.36 REMARK 500 LEU B 385 32.82 -96.28 REMARK 500 ASP B 399 -113.64 56.46 REMARK 500 GLN B 429 42.87 -88.86 REMARK 500 THR B 468 48.71 -105.50 REMARK 500 PHE B 473 -142.61 -107.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G98 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G98 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3E87 RELATED DB: PDB REMARK 900 RELATED ID: 3E88 RELATED DB: PDB REMARK 900 RELATED ID: 3E8C RELATED DB: PDB REMARK 900 RELATED ID: 3E8E RELATED DB: PDB DBREF 3E8D A 146 480 UNP P31751 AKT2_HUMAN 146 480 DBREF 3E8D B 146 480 UNP P31751 AKT2_HUMAN 146 480 DBREF 3E8D C 3 12 UNP P49841 GSK3B_HUMAN 3 12 DBREF 3E8D D 3 12 UNP P49841 GSK3B_HUMAN 3 12 SEQADV 3E8D ASP A 474 UNP P31751 SER 474 ENGINEERED MUTATION SEQADV 3E8D ASP B 474 UNP P31751 SER 474 ENGINEERED MUTATION SEQRES 1 A 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 A 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 A 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 A 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 A 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 A 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 A 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 A 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 A 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 A 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 A 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 A 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 A 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 A 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 A 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 A 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 A 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 A 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 A 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 A 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 A 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 A 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 A 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 A 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 A 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 A 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG SEQRES 1 B 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 B 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 B 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 B 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 B 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 B 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 B 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 B 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 B 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 B 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 B 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 B 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 B 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 B 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 B 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 B 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 B 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 B 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 B 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 B 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 B 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 B 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 B 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 B 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 B 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 B 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU SEQRES 1 D 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3E8D TPO A 309 THR PHOSPHOTHREONINE MODRES 3E8D TPO B 309 THR PHOSPHOTHREONINE HET TPO A 309 11 HET TPO B 309 11 HET G98 A 1 34 HET G98 B 1 34 HETNAM TPO PHOSPHOTHREONINE HETNAM G98 4-[2-(4-AMINO-2,5-DIHYDRO-1,2,5-OXADIAZOL-3-YL)-6- HETNAM 2 G98 {[(1S)-3-AMINO-1-PHENYLPROPYL]OXY}-1-ETHYL-1H- HETNAM 3 G98 IMIDAZO[4,5-C]PYRIDIN-4-YL]-2-METHYLBUT-3-YN-2-OL HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 G98 2(C24 H29 N7 O3) FORMUL 7 HOH *41(H2 O) HELIX 1 1 THR A 148 ASN A 150 5 3 HELIX 2 2 LYS A 185 LYS A 191 1 7 HELIX 3 3 GLU A 193 THR A 207 1 15 HELIX 4 4 LEU A 237 ARG A 245 1 9 HELIX 5 5 THR A 248 ARG A 269 1 22 HELIX 6 6 LYS A 277 GLU A 279 5 3 HELIX 7 7 THR A 313 LEU A 317 5 5 HELIX 8 8 ALA A 318 GLU A 323 5 6 HELIX 9 9 ALA A 330 GLY A 346 1 17 HELIX 10 10 ASP A 354 GLU A 365 1 12 HELIX 11 11 SER A 374 LEU A 385 1 12 HELIX 12 12 ASP A 388 ARG A 392 5 5 HELIX 13 13 ASP A 399 GLU A 405 1 7 HELIX 14 14 HIS A 406 LEU A 410 5 5 HELIX 15 15 ASN A 413 GLN A 419 1 7 HELIX 16 16 ASP A 440 ALA A 445 1 6 HELIX 17 17 THR B 148 ASN B 150 5 3 HELIX 18 18 LYS B 185 LYS B 191 1 7 HELIX 19 19 GLU B 193 THR B 207 1 15 HELIX 20 20 LEU B 237 ARG B 245 1 9 HELIX 21 21 THR B 248 ARG B 269 1 22 HELIX 22 22 LYS B 277 GLU B 279 5 3 HELIX 23 23 THR B 313 LEU B 317 5 5 HELIX 24 24 ALA B 318 GLU B 323 5 6 HELIX 25 25 ALA B 330 GLY B 346 1 17 HELIX 26 26 ASP B 354 GLU B 365 1 12 HELIX 27 27 SER B 374 LEU B 385 1 12 HELIX 28 28 ASP B 399 GLU B 405 1 7 HELIX 29 29 HIS B 406 LEU B 410 5 5 HELIX 30 30 ASN B 413 GLN B 419 1 7 HELIX 31 31 ASP B 440 ALA B 445 1 6 SHEET 1 A 5 PHE A 152 LYS A 160 0 SHEET 2 A 5 GLY A 164 GLU A 171 -1 O VAL A 166 N GLY A 159 SHEET 3 A 5 TYR A 177 ARG A 184 -1 O ILE A 182 N LYS A 165 SHEET 4 A 5 ARG A 224 GLU A 230 -1 O LEU A 225 N LEU A 183 SHEET 5 A 5 LEU A 215 GLN A 220 -1 N TYR A 217 O VAL A 228 SHEET 1 B 3 GLY A 235 GLU A 236 0 SHEET 2 B 3 LEU A 281 LEU A 283 -1 O LEU A 283 N GLY A 235 SHEET 3 B 3 ILE A 289 ILE A 291 -1 O LYS A 290 N MET A 282 SHEET 1 C 2 VAL A 271 VAL A 272 0 SHEET 2 C 2 LYS A 298 GLU A 299 -1 O LYS A 298 N VAL A 272 SHEET 1 D 2 CYS A 311 GLY A 312 0 SHEET 2 D 2 PHE C 10 ALA C 11 -1 O PHE C 10 N GLY A 312 SHEET 1 E 5 PHE B 152 LYS B 160 0 SHEET 2 E 5 GLY B 164 GLU B 171 -1 O VAL B 166 N GLY B 159 SHEET 3 E 5 TYR B 177 ARG B 184 -1 O ILE B 182 N LYS B 165 SHEET 4 E 5 ARG B 224 GLU B 230 -1 O LEU B 225 N LEU B 183 SHEET 5 E 5 LEU B 215 GLN B 220 -1 N TYR B 217 O VAL B 228 SHEET 1 F 3 GLY B 235 GLU B 236 0 SHEET 2 F 3 LEU B 281 LEU B 283 -1 O LEU B 283 N GLY B 235 SHEET 3 F 3 ILE B 289 ILE B 291 -1 O LYS B 290 N MET B 282 SHEET 1 G 2 VAL B 271 VAL B 272 0 SHEET 2 G 2 LYS B 298 GLU B 299 -1 O LYS B 298 N VAL B 272 SHEET 1 H 2 CYS B 311 GLY B 312 0 SHEET 2 H 2 PHE D 10 ALA D 11 -1 O PHE D 10 N GLY B 312 LINK C LYS A 308 N TPO A 309 1555 1555 1.33 LINK C TPO A 309 N PHE A 310 1555 1555 1.33 LINK C LYS B 308 N TPO B 309 1555 1555 1.33 LINK C TPO B 309 N PHE B 310 1555 1555 1.33 SITE 1 AC1 21 LYS A 160 GLY A 161 GLY A 164 LYS A 165 SITE 2 AC1 21 VAL A 166 ALA A 179 LYS A 181 GLU A 200 SITE 3 AC1 21 LEU A 204 PHE A 227 MET A 229 GLU A 230 SITE 4 AC1 21 TYR A 231 ALA A 232 ASN A 280 MET A 282 SITE 5 AC1 21 THR A 292 ASP A 293 PHE A 294 PHE A 439 SITE 6 AC1 21 SER C 9 SITE 1 AC2 19 GLY B 161 GLY B 164 VAL B 166 ALA B 179 SITE 2 AC2 19 LYS B 181 GLU B 200 LEU B 204 PHE B 227 SITE 3 AC2 19 MET B 229 GLU B 230 TYR B 231 ALA B 232 SITE 4 AC2 19 ASN B 280 MET B 282 THR B 292 ASP B 293 SITE 5 AC2 19 PHE B 294 PHE B 439 SER D 9 CRYST1 116.823 116.823 45.102 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008560 0.004942 0.000000 0.00000 SCALE2 0.000000 0.009884 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022172 0.00000